Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Advies: vergoed avalglucosidase alfa (Nexviadyme) voor behandeling ziekte van Pompe
jun 2024 | Neuro-musculair